Davis Polk & Wardwell, Maples and Calder and JunHe advised Credo Technology Group Holding Ltd on the offering. Credo Technology Group Holding Ltd (Nasdaq: CRDO) (“Credo”) announced...
Credo’s $201.3 Million Follow-On Offering
Gerd Hegele Joins Paul Hastings as a Partner in Frankfurt
Continuing the expansion of its European financial and infrastructure offerings, Paul Hastings (Europe) LLP announced that Gerd Hegele has joined the firm as a partner in...
RAPT Therapeutics’ $150 Million At-The-Market Offering
Cooley advised RAPT Therapeutics, Inc. and Davis Polk & Wardwell advised the sales agents on the offering. RAPT Therapeutics, Inc. (Nasdaq:RAPT) announced the SEC-registered at-the-market offering of its common...
Texas Instruments’ $1.6 Billion Notes Offering
Davis Polk advised Texas Instruments Incorporated on the transaction. Texas Instruments Incorporated (TI) (Nasdaq: TXN) announced the pricing of three series of senior unsecured notes for...
Amazon.com’s $8.25 Billion Notes Offering
Gibson, Dunn & Crutcher advised Amazon.com, while Davis Polk advised the representatives of the underwriters in the offering. Amazon.com, Inc. executed its offering, consisting of $1.25...
Curaleaf’s Acquisition of Majority Stake and Strategic Partnership With Four 20 Pharma
Gleiss Lutz advised Curaleaf in the transaction while Paul Hastings represented Four 20 Pharma. Curaleaf Holdings, Inc., a leading U.S. provider of consumer products in cannabis,...